Variations in gene expression among individuals may have multiple downstream implications, including an effect on disease risk. 'Genetical genomics' (or expression genetics) uses linkage and association methods to map gene expression phenotypes, connecting genetic variants to expression quantitative trait loci (eQTLs). It represents a promising approach to identifying novel expression-regulatory elements in the genome. Studies of human lymphoblastoid cell lines, 1 liver 2 and brain 3 have also been reported. Meyers et al. 3 studied 193 neuropathologically normal human brain samples from three cortical regions using the Affymetrix 500K Array for genotyping and the Illumina HumanRefseq-8 Expression Array for gene expression measurements. They assessed association between 366 140 single-nucleotide polymorphisms (SNPs) and the expression of 14 078 transcripts, and identified 433 SNP-transcript pairs (99 transcripts) that showed significant cis-association (transcript-specific empirical P-value p0.05); but only 25 of them (involving two genes, KIF1B and IPP) appear significant after correcting for all the SNPs and phenotypes (transcripts) tested (Sidak multi-transcript-corrected empirical P-values p0.05). We would consider only the two genes truly significant cisassociations as they were the ones surviving correction for all the statistical tests.
There are several major limitations in the Myers et al. study, including sample heterogeneity (pooled samples from three different cortical regions: frontal, temporal and parietal), expression data confounded by uncontrolled covariates, particularly brain pH value, and microarray batch effects. In any case, it would be reasonable to attempt a replication study. We performed a new brain eQTL mapping using psychiatric patients and control brains, focusing on the prefrontal cortex and with a statistical procedure optimized for covariates and microarray batch effects. We used Surrogate Variable Analysis (SVA) 4 to remove covariate effects and ComBat 5 to remove batch effects on gene expression before the SNP-expression association tests. These procedures, we hoped, would improve the power of detecting associations by removing sources of non-genetic variation from the data.
We obtained 164 brain samples from the Stanley Medical Research Institute (SMRI). These 164 samples came from two collections: [6] [7] [8] (1) the Neuropathology Consortium has 60 brain samples, with 56 of them obtained from Caucasian individuals of schizophrenia, bipolar disorder, major depression patients and healthy controls; (2) the SMRI Array Collection contains another set of 105 samples, with 103 of them from Caucasians with schizophrenia and bipolar disorder, or from healthy controls. Diagnoses of the samples were made by two senior psychiatrists, using the DSM-IV criteria and based on medical records, and, when possible, telephone interviews with family members. Diagnoses of unaffected controls were based on structured interviews by a senior psychiatrist with family member(s) to rule out Axis-I diagnoses.
The above two sets of samples have been studied for gene expression in the prefrontal cortex (Broadmann area 46, dorsolateral prefrontal cortex, possibly contains Broadmann area 10, frontal pole) by six investigators using five different microarray platforms. Data are available at the SMRI Online Genomics Database (https://www.stanleygenomics.org). Altar's group is the only one that studied both Consortium and Array samples using the same microarray platform (Affymetrix Human Genome U133A). We chose this data set (Study 1 and 2 in the online database) as our expression data and obtained the CEL files of the raw gene expression data. These include 87 Array and 40 Consortium Caucasian samples. All these expression data were normalized with the robust multi-array average method using the Partek software (http://www. partek.com). Robust multi-array average expression values were calculated based on scaling to a target intensity of 100, transformed by log 2 (x þ 20). The Affymetrix U133A array uses, on average, 11 probes of a probeset to assay the expressions of 3 0 of one transcript. The probeset is the expression measurement unit (phenotype) in this study. A total of 22 277 probesets were assayed in U133A. We selected 6968 probesets that were coded as 'present' by the Affymetrix Microarray Suite (MAS) call algorithm in X80% of samples.
We used SVA 4 to identify known and unknown covariates influencing the gene expression data. The residuals from SVA were then used for ComBat 5 to remove batch effects. The effects of known variables on the gene expression data were identified using linear regression pre-and post-SVA, and ComBat. All samples include data on collection group, diagnosis, age, gender, race, postmortem interval, brain pH, smoking, alcohol use, suicide status and psychotic feature. We used these variables as covariates in the analysis. Drug and alcohol use were dichotomized into 'Heavy' and 'Not heavy' (as defined by SMRI). Age, postmortem interval, pH and lifetime antipsychotics data were analyzed as quantitative covariates. Other covariates were analyzed as binary covariates. Summary information on the sample demographic data and covariates can be found in Supplementary  Table ST1 .
The raw microarray expression data demonstrated strong effects of brain pH (significant in 57% of probes) and batch effects (significant in 48% of probes). After SVA and ComBat processing, and assessing the significance of covariates by permuting within batches, the proportions of genes showing significant pH and batch effects (P < 0.05) were reduced to 2 and 5%, respectively, which are close to chance expectation (Supplementary Table ST2 ).
The 6968 residuals obtained from SVA/ComBat were used as phenotypes for association analysis. All residuals were standardized to have a mean of 0 and standard deviation of 1.
Genomic DNAs of the same individuals were extracted from frozen cerebellum tissues provided by the SMRI. A phenol/chloroform/isoamyl alcohol protocol 9 was modified and followed. The DNAs were resuspended in 0.1 mM EDTA TE buffer. The genomic DNA was evaluated with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) for concentration and using 1% agarose gel to validate the DNA integrity. We used the GeneChip Mapping 5.0K Array and Assay kit (Affymetrix, Santa Clara, CA, USA) for genotyping following the Affymetrix protocol. Genotypes were called using the BRLMM-p algorithm (Affymetrix) with all arrays simultaneously. SNP call rates ranged from 97.3 to 99.58% (average 98.9%). In the 156 Caucasian samples, 238 389 out of 443 816 SNPs have call rates X99%, minor allele frequency X10% and HardyWeinberg Equilibrium P-value X0.001. These 238 389 SNPs were used to test for correlations with gene expression.
We used the programs STRUCTURE, 10 PLINK 11 and EIGENSTRAT 12 to verify sample ethnic homogeneity, and PLINK 11 pairwise identity-by-state and identityby-descent calculation to examine cryptic relatedness. The results confirmed that 127 selected samples were from unrelated Caucasians, and these were used for genotype-expression association tests.
Gene expression regulation can be roughly divided into two types: cis-acting regulation by DNA elements in or adjacent to the transcripts and trans-acting regulation by factors from the genomic regions distal from the transcripts, including from different chromosomes. We defined the SNPs within a region bound by 1-Mb distance from both ends of each expression probeset as candidates for cis-analysis. All the other SNPs were analyzed for trans-acting associations of each gene. Forty expression probesets were excluded from the cis-analysis because of their having multiple homologs in the genome. They were analyzed by other trans-analyses procedures using all SNPs as trans-candidate SNPs for them.
We used PLINK 11 to perform linear regression analysis to test for correlation between expression residuals and genotype (additive genetic model; the number of minor alleles at each SNP). From this analysis, an asymptotic P-value from the Wald statistic was obtained. All permutations were performed by permuting within mRNA microarray and genotyping batch clusters to control for batch effects. Permutations were performed by swapping sets of phenotypes between individuals. This preserves the relationship between genotypes (and controls for linkage disequilibrium) and within the grouped phenotypes (thus controlling for any correlations between expression probes). Clusters of individuals within each mRNA microarray and genotype batch were defined. Permutations were performed within each cluster of individuals to control for batch effects. Two sets of permutations were performed. Permutations for an expression-SNP combination were calculated with the adaptive perm option of PLINK, permuting up to 1 billion replicates (EMP_P). This corrects for possible non-normality of the phenotype distribution. Permutations correcting for multiple testing within a cis-region or whole-genome scan were also performed, using the max(T) permutation option of PLINK (Regionwide_P for cis; Genomewide_P for trans). For each phenotype, results were permutated 1000 times, using the same seed to maintain the correlation between phenotypes. The most significant statistic per replicate was saved using the PLINK mperm-save option. To estimate phenotype-wide significance, the most significant statistic per replicate across all phenotypes was obtained (stat best ). Phenotype-wide corrected P-values were calculated as (R þ 1)/(N þ 1), where R is the number of times the stat best exceeded the observed statistic and N is the number of permutations (1000).
In the cis-analysis, 3951 SNP-expression probeset pairs, consisting of 3530 SNPs and 903 probesets (of 826 genes), were significantly correlated with regionwide permutated P-value (Regionwide_P) p0.05. We found that 562 associations (involving 106 genes) are significant after correcting for the 6928 expression phenotypes that have been tested for cis-association (Phenotype-wide_P p0.05). Seventy-two expression probesets had 3-20 different SNPs from each cisregion showing phenotype-wide significant associations. They are eQTLs supported by multiple SNPs in the same region. The cis-associations show effect sizes R2 ranging from 0.05 to 0.67. The top 10 best signals by Wald P of these 106 genes are shown in Table 1 . The complete cis-regulation list can be found in Supplementary Table ST3 .
In the trans-analysis, 241 SNP-transcript probeset pairs from 239 SNPs and 160 probesets (157 genes) had associations at permutation-corrected Genomewide_P p0.05 (Supplementary Table ST4 ); but none was significant after further phenotype-wide correction.
Interestingly, pathway and functional analysis of the regulated genes in both cis-and trans-associations using Ingenuity Pathway Analysis (www.ingenuity. com) show that 'protein degradation and protein synthesis' are the most enriched function groups. Protein ubiquitination is the most enriched canonical pathway (Supplement table ST5 ). This suggests that protein metabolism may be impacted by the genetic variants, with detectable effects more than that in other biological systems.
We detected one SNP (rs17733118, upstream of ZFP64, a zinc-finger protein homolog) showing associations with two distinct genes VPS8 and CTNNA1. ZFP64 is thus a potential shared regulator that regulates the expression of VPS8 and CTNNA1, although nothing is known about their interactions so far. Again worth noting is that these trans-associations do not reach a phenotype-wide significance level, therefore with a good possibility of being false-positive.
In the previous study of brain samples 3 Myers et al. identified 433 SNP-transcript pairs (99 transcripts) showing region-wide cis-association (corrected for all the SNPs tested in each cis-region), but only identified two genes showing phenotype-wide significant cis-association. We analyzed 366 genes, which showed region-wide significant cis-association in our study, in the 46 frontal cortex subset samples from Myers' study using our SVA-ComBat procedure. To maximize power, missing data were imputed using nearest-neighbor averaging prior to SVA analyses. Information was available for sex, age, transcript detected rate, sample collection institution and batch dates (but not brain pH). Effects of these covariates were analyzed using regression in the pre-and post-SVA þ ComBat data. In the preprocessed data, batch effects, institution and transcript detected rate were significant in 40, 15 and 20% of the probes. In the post-processed data and permuting within batch cluster, batch effects, institution and transcript detected rate appeared significant in 5, 6 and 0% of the probes. Association analyses were performed in the same manner as with the SMRI data. Only the SNPs that were significant in our study were tested. Thus region-wide significance refers to significance after correction for the number of SNPs actually analyzed rather than for the whole cis-region. Of the 826 genes showing associations with a Regionwide_P < 0.05 in the SMRI data, only 366 genes could be tested in the Myers data. Defining replication as only association with the same SNP in the same direction (same allele increases or decreases gene expression), 103 associations involving 45 genes are replicated at the region-wide significant level. Among them 26 associations involving seven genes show phenotype-wide significance in the replicate sample ( Table 2 shows the best association for each of the 45 genes).
The relatively low level of replication is not surprising and lack of replication does not invalidate either set of findings. The replicate sample size is quite small (only 46 samples). Normally the replicate sample size should be larger than that in the initial study to have sufficient power to reproduce the findings from the initial study. Also there is a phenotype; No. SNP tested, number of SNPs that have been tested for each gene in the 2 Mb cis-region; Phenotype-wide_P, empirical P-value based on 1000 permutations, correcting for the number of SNPs tested for cis-associations of each expression probeset and the number of probeset (phenotypes) studied; Regionwide_ P, empirical P-value based on 1000 permutations with correction for the number of SNPs tested for cis-associations of each expression probeset; Wald_P: Wald test asymptotic P-value. Complete list of cis-associations can be found in Supplementary Table ST3 Table 2 Cis-associations that are region-wide and/or phenotype-wide significant in both SMRI and Myers' samples in the same association direction (best association for each gene) Abbreviations: Phenotype-wide_P, empirical P-value based on 1000 permutations, correcting for the number of SNPs tested for cis-associations of each expression probeset and the number of probeset (phenotypes) studied; Regionwide_P, empirical P-value based on 1000 permutations with correction for the number of SNPs tested for cisassociations of each expression probeset; SMRI, Stanley Medical Research Institute; SNP, single-nucleotide polymorphism; Wald_P: Wald test asymptotic P-value.
brain-region difference (frontal cortex in Myers' study; prefrontal cortex in our study) and demographic data differences (average age 81 years for Myers' samples; in this study average age is 45 years). Myers et al. reported RPS26 gene association with SNP rs11171739 as an example of replicating Cheung et al.'s 1 finding in lymphoblastoid cells. We observed this association as well. Another study of liver also identified RPS26-rs2292239 correlation as one of its strongest associations 2 . RPS26 seems to be one of the most strongly genetically regulated genes in the human genome.
Seven SNPs in a 125-kb genomic region showed cisassociation with two different genes, ALDH8A1 and HBS1L, at the phenotype-wide significance level (Table 3) . They may be considered as co-regulated transcripts. ALDH8A1 and HBS1L are transcribed in the same direction, with increased expression associated with the same SNP allele. They might be derived from a polycistronic transcript, although polycistronic transcription, except for microRNA cluster, has rarely been reported or studied in humans so far. 13 Since the samples in this study are from psychiatric disorder patients and controls, we were interested in knowing whether the sample composition influenced the detected regulation elements. In the covariate analysis of the expression data, we found that disease diagnoses contribute very little to the global variations of gene expression level before and after the SVA/ComBat adjustment, comparing with many other factors, including postmortem interval, brain pH (Supplementary Table 2 ). After regressing out factors including affection status, we found that affection status has little effect on the eQTL mapping results in this study.
It is conceivable that genetic variants would have stronger and direct impact on regional cis-regulation of gene expression, while distant trans-regulation would involve more factors and thus show less genetic effects. We identified an exceedingly large amount of cis-associations that can stand the strict statistical correction for multiple testing. No trans-associations were significant after correction for the number of SNPs and phenotypes analyzed. Other eQTL studies have claimed detection of trans-regulations with region-wide and occasionally phenotype-wide significance, but there is little consistency between studies. [14] [15] [16] [17] The difficulty of replicating trans-eQTLs has previously been observed. 15 We are advocating the use of phenotype-wide significance, which might help to reduce the false positives that would be more difficult to replicate.
We note that this study focuses on genes that have observable, relatively large variation in expression, and on SNPs that have common minor allele frequencies, in order to have well-powered SNPexpression pairs for eQTL mapping study. A considerable number of important neuropsychiatric disease candidate genes, including 5-HTT (SLC6A4), DRD1, DRD2, DRD3, DRD4, DRD5, GRIA1, GRIA3, GRIA4, GRIN1, GRIN2B, GRIN2C, GRIN2D, PER1, CRY1, CRY2 and others, were not assessed in this study because their expression probes were filtered out due to low expression signal levels.
Data and biomaterial access
The genotype and expression data files mentioned in the paper are available at https://www.stanleygen omics.org/index.html and upon request from the authors. DNA and RNA samples are also available for application through SMRI (http://www.stanleyresearch. Abbreviations: Beta, regression coefficient; Phenotype-wide_P, empirical P-value based on 1000 permutations, correcting for the number of SNPs tested for cis-associations of each expression probeset and the number of probeset (phenotypes) studied; R2, the proportion of phenotypic variance due to the SNP; Regionwide_P, empirical P-value based on 1000 permutations with correction for the number of SNPs tested for cis-associations of each expression probeset; SNP, single-nucleotide polymorphism.
